• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.

作者信息

Hidaka H, Hayashi H, Kohri H, Kimura Y, Hosokawa T, Igawa T, Saitoh Y

出版信息

J Pharmacol Exp Ther. 1979 Oct;211(1):26-30.

PMID:226672
Abstract
摘要

相似文献

1
Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.血小板环磷酸腺苷磷酸二酯酶的选择性抑制剂西洛酰胺可抑制血小板聚集。
J Pharmacol Exp Ther. 1979 Oct;211(1):26-30.
2
Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.己酮可可碱对血小板环3',5'-腺苷单磷酸磷酸二酯酶的抑制作用。
Arzneimittelforschung. 1975 May;25(5):740-1.
3
[Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].[环核苷酸磷酸二酯酶抑制剂的药理价值]
Ann Pharm Fr. 1984;42(2):99-112.
4
Y-590 (a new pyridazinone derivative), a potent anti-thrombotic agent--II. Inhibition of platelet phosphodiesterase.Y-590（一种新型哒嗪酮衍生物），一种强效抗血栓形成剂——II. 对血小板磷酸二酯酶的抑制作用
Thromb Res. 1984 Sep 1;35(5):589-94. doi: 10.1016/0049-3848(84)90291-3.
5
HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.HL 725是一种极其强效的血小板磷酸二酯酶抑制剂，可在体外诱导血小板聚集。
Life Sci. 1982 Nov 8;31(19):2037-43. doi: 10.1016/0024-3205(82)90095-9.
6
Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.米帕林引起洗过的兔血小板中环鸟苷酸水平升高以及加速二磷酸腺苷诱导的聚集的逆转。
J Cyclic Nucleotide Protein Phosphor Res. 1983;9(4-5):341-53.
7
A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.一种具有潜在强心和抗血栓形成特性的强效且选择性的环磷酸腺苷磷酸二酯酶抑制剂。
Mol Pharmacol. 1986 Jun;29(6):554-60.
8
Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.环磷酸鸟苷磷酸二酯酶特异性抑制剂1-(3-氯苯胺基)-4-苯基酞嗪（MY-5445）对人血小板聚集的影响
J Pharmacol Exp Ther. 1984 Feb;228(2):467-71.
9
Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.一种半合成类黄酮——扁柏黄酮六乙酸酯对人血小板环磷酸腺苷磷酸二酯酶及血小板聚集的抑制作用
Biochem Pharmacol. 1986 Jan 15;35(2):257-62. doi: 10.1016/0006-2952(86)90523-x.
10
Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.腺苷对人血小板中环磷酸腺苷水平的影响及其与腺苷掺入和血小板聚集的关系。
Mol Pharmacol. 1975 Sep;11(5):528-44.

引用本文的文献

1
The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued bycilostamide.CL 316,243 的降血糖作用随着重复使用而消失，并被西洛酰胺挽救。
Physiol Rep. 2022 Feb;10(4):e15187. doi: 10.14814/phy2.15187.
2
Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells.不同磷酸二酯酶亚型在 INS-1 细胞和人胰腺β细胞中环腺苷酸积累和活性的调节。
PLoS One. 2019 Aug 23;14(8):e0215188. doi: 10.1371/journal.pone.0215188. eCollection 2019.
3
Open-Label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Internal Carotid Artery Stent Placement.
评估西洛他唑在接受颈内动脉支架置入术患者中的安全性和有效性的开放标签I期临床研究。
Interv Neurol. 2017 Mar;6(1-2):42-48. doi: 10.1159/000452308. Epub 2016 Dec 8.
4
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient.扎达维林对一名科斯特洛综合征患者胚胎性横纹肌肉瘤的细胞毒性
Front Oncol. 2017 Apr 3;7:42. doi: 10.3389/fonc.2017.00042. eCollection 2017.
5
Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?环核苷酸磷酸二酯酶抑制剂可否成为治疗帕金森病的药物？
Mol Neurobiol. 2018 Jan;55(1):822-834. doi: 10.1007/s12035-016-0355-8. Epub 2017 Jan 6.
6
Cardiac cAMP: production, hydrolysis, modulation and detection.心脏环磷酸腺苷：生成、水解、调节与检测
Front Pharmacol. 2015 Oct 1;6:203. doi: 10.3389/fphar.2015.00203. eCollection 2015.
7
Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.不同亚型的环磷酸腺苷磷酸二酯酶对心脏兴奋-收缩偶联的调节作用。
Cardiovasc Res. 2013 Nov 1;100(2):336-46. doi: 10.1093/cvr/cvt193. Epub 2013 Aug 9.
8
Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation.利钠肽诱导心脏交感神经元儿茶酚胺释放：组胺 H3 和 H4 受体激活的抑制作用。
J Pharmacol Exp Ther. 2012 Dec;343(3):568-77. doi: 10.1124/jpet.112.198747. Epub 2012 Aug 24.
9
An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.利钠肽的一个意外特性：通过蛋白激酶 G 介导的磷酸二酯酶 3 抑制促进钙依赖性儿茶酚胺释放。
Circulation. 2012 Jan 17;125(2):298-307. doi: 10.1161/CIRCULATIONAHA.111.059097. Epub 2011 Dec 9.
10
Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.环核苷酸磷酸二酯酶（PDE）同工酶作为细胞内信号网络的靶点：PDE 抑制剂在各种疾病中的益处及未来治疗发展的展望。
Br J Pharmacol. 2012 Mar;165(5):1288-305. doi: 10.1111/j.1476-5381.2011.01729.x.